Campbell & CO Investment Adviser LLC Veracyte, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.27 Billion
- Q1 2025
A detailed history of Campbell & CO Investment Adviser LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 76,342 shares of VCYT stock, worth $1.83 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
76,342Holding current value
$1.83 Million% of portfolio
0.18%Shares
8 transactions
Others Institutions Holding VCYT
# of Institutions
303Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$198 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$187 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$126 Million0.27% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$92.4 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$91.1 Million0.85% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.72B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...